Status:
COMPLETED
Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment
Lead Sponsor:
Université Libre de Bruxelles
Collaborating Sponsors:
Jules Bordet Institute
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Background: The end of treatment is for cancer patients the beginning of a critical rehabilitation period including numerous physical, emotional, professional and cognitive challenges. Specific interv...
Eligibility Criteria
Inclusion
- Non-metastatic breast cancer (in situ or invesive)
- End of active treatments (surgery, chemotherapy and radiotherapy)
- No recurrence nor palliative care
- Min. 18 years
- Able to speak French
- Willing to be randomized to study intervention group
- Accept to give their written informed consent
Exclusion
- No cognitive dysfunction
- No severe or uncontrolled psychiatric illness
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2015
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT01797354
Start Date
July 1 2011
End Date
September 1 2015
Last Update
September 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Jules Bordet
Brussels, Belgium, 1000